Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)

• Company Description    Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. Number of Employees: 193

• Price / Volume Information    Yesterday's Closing Price: $2.88 Daily Weekly Monthly 20 Day Moving Average: 155,992 shares Shares Outstanding: 70.33 (millions) Market Capitalization: $202.56 (millions) Beta: 0.82 52 Week High: $16.61 52 Week Low: $2.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.21% -17.29% 12 Week -16.76% -12.37% Year To Date -60.28% -53.69%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 351 NEW WHITFIELD STREET - GUILFORD,CT 06437 USA ph: 203-458-7100 fax: - investors@hyperfine.io https://hyperfine.io

• General Corporate Information    Officers Dave Scott - Chief Executive Officer; President and Director R. Scott Huennekens - Executive Chairman of the Board John Dahldorf - Vice Chairman of the Board Alok Gupta - Chief Financial Officer Ruth Fattori - Director Peer Information Hyperfine, Inc. (ABMD) Hyperfine, Inc. (DMDS) Hyperfine, Inc. (CPWY.) Hyperfine, Inc. (EQUR) Hyperfine, Inc. (ECIA) Hyperfine, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 44916K106 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 70.33 Most Recent Split Date: (:1) Beta: 0.82 Market Capitalization: $202.56 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.22 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 87.55% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 246.10% ROE 03/31/22 - -59.73 12/31/21 - -60.78 09/30/21 - - ROA 03/31/22 - -26.18 12/31/21 - -13.81 09/30/21 - - Current Ratio 03/31/22 - 15.22 12/31/21 - 12.55 09/30/21 - 0.48 Quick Ratio 03/31/22 - 14.82 12/31/21 - 12.28 09/30/21 - 0.48 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - -4,155.89 12/31/21 - -4,334.96 09/30/21 - - Book Value 03/31/22 - 2.37 12/31/21 - 2.65 09/30/21 - -0.39 Inventory Turnover 03/31/22 - 1.57 12/31/21 - 2.47 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - - Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - -

Powered by Zacks Investment Research ©